Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Sex differences in cytokine production following West Nile virus infection: Implications for symptom manifestation.

Hoffman KW, Lee JJ, Foster GA, Krysztof D, Stramer SL, Lim JK.

Pathog Dis. 2019 Mar 1;77(2). pii: ftz016. doi: 10.1093/femspd/ftz016.

PMID:
30915442
2.

Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.

Brown JA, Singh G, Acklin JA, Lee S, Duehr JE, Chokola AN, Frere JJ, Hoffman KW, Foster GA, Krysztof D, Cadagan R, Jacobs AR, Stramer SL, Krammer F, García-Sastre A, Lim JK.

Immunity. 2019 Mar 19;50(3):751-762.e5. doi: 10.1016/j.immuni.2019.01.005. Epub 2019 Feb 5.

PMID:
30737148
3.

Impact of one-time testing for Trypanosoma cruzi antibodies among blood donors in the United States.

Dodd RY, Groves JA, Townsend RL, Notari EP, Foster GA, Custer B, Busch MP, Stramer SL.

Transfusion. 2019 Mar;59(3):1016-1023. doi: 10.1111/trf.15118. Epub 2018 Dec 26.

PMID:
30588627
4.

CagY-Dependent Regulation of Type IV Secretion in Helicobacter pylori Is Associated with Alterations in Integrin Binding.

Skoog EC, Morikis VA, Martin ME, Foster GA, Cai LP, Hansen LM, Li B, Gaddy JA, Simon SI, Solnick JV.

MBio. 2018 May 15;9(3). pii: e00717-18. doi: 10.1128/mBio.00717-18.

5.

Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model.

Duehr J, Lee S, Singh G, Foster GA, Krysztof D, Stramer SL, Bermúdez González MC, Menichetti E, Geretschläger R, Gabriel C, Simon V, Lim JK, Krammer F.

mSphere. 2018 Feb 7;3(1). pii: e00011-18. doi: 10.1128/mSphereDirect.00011-18. eCollection 2018 Jan-Feb.

6.

Discordant human T-lymphotropic virus screening with Western blot confirmation: evaluation of the dual-test algorithm for US blood donations.

Stramer SL, Townsend RL, Foster GA, Johnson R, Weixlmann B, Dodd RY.

Transfusion. 2018 Mar;58(3):638-640. doi: 10.1111/trf.14471. Epub 2018 Jan 10.

PMID:
29322517
7.

Bio-synthetic materials for immunomodulation of islet transplants.

Foster GA, García AJ.

Adv Drug Deliv Rev. 2017 May 15;114:266-271. doi: 10.1016/j.addr.2017.05.012. Epub 2017 May 19. Review.

8.

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, García-Sastre A, Krammer F, Lim JK.

Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30.

9.

Protease-degradable microgels for protein delivery for vascularization.

Foster GA, Headen DM, González-García C, Salmerón-Sánchez M, Shirwan H, García AJ.

Biomaterials. 2017 Jan;113:170-175. doi: 10.1016/j.biomaterials.2016.10.044. Epub 2016 Oct 28.

10.

Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States.

Crowder LA, Steele WR, Notari EP 4th, Hopkins CK, Lima JL, Foster GA, Townsend RL, Krysztof DE, Dodd RY, Stramer SL.

Transfusion. 2017 Feb;57(2):404-411. doi: 10.1111/trf.13891. Epub 2016 Nov 2.

PMID:
27807863
11.

Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States.

Dodd RY, Notari EP, Nelson D, Foster GA, Krysztof DE, Kaidarova Z, Milan-Benson L, Kessler DA, Shaz BH, Vahidnia F, Custer B, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study (REDS)-II.

Transfusion. 2016 Nov;56(11):2781-2789. doi: 10.1111/trf.13759. Epub 2016 Aug 25.

PMID:
27557553
12.

Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season.

Grinev A, Chancey C, Volkova E, Añez G, Heisey DA, Winkelman V, Foster GA, Williamson P, Stramer SL, Rios M.

PLoS Negl Trop Dis. 2016 May 16;10(5):e0004717. doi: 10.1371/journal.pntd.0004717. eCollection 2016 May.

13.

Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection.

Hoffman KW, Sachs D, Bardina SV, Michlmayr D, Rodriguez CA, Sum J, Foster GA, Krysztof D, Stramer SL, Lim JK.

J Infect Dis. 2016 Aug 15;214(4):634-43. doi: 10.1093/infdis/jiw179. Epub 2016 May 3.

14.

Two human immunodeficiency virus Type 2 cases in US blood donors including serologic, molecular, and genomic characterization of an epidemiologically unusual case.

Stramer SL, Yu G, Herron R, Espinoza N, Foster GA, Naccache SN, Brodsky JP, Ong E, Linnen JM, Dyer N, Styer LM, Parker MM, Chiu CY.

Transfusion. 2016 Jun;56(6 Pt 2):1560-8. doi: 10.1111/trf.13600. Epub 2016 Apr 15.

PMID:
27079968
15.

11,12-Epoxyecosatrienoic acids mitigate endothelial dysfunction associated with estrogen loss and aging: Role of membrane depolarization.

Sun C, Simon SI, Foster GA, Radecke CE, Hwang HV, Zhang X, Hammock BD, Chiamvimonvat N, Knowlton AA.

J Mol Cell Cardiol. 2016 May;94:180-188. doi: 10.1016/j.yjmcc.2016.03.019. Epub 2016 Apr 11.

16.

Sexually transmitted infections in U.S. Air Force recruits in basic military training.

Webber BJ, Pawlak MT, Jones NM, Tchandja JN, Foster GA.

MSMR. 2016 Feb;23(2):16-9.

PMID:
26930147
17.

Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto Rico.

Añez G, Heisey DA, Chancey C, Fares RC, Espina LM, Souza KP, Teixeira-Carvalho A, Krysztof DE, Foster GA, Stramer SL, Rios M.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004445. doi: 10.1371/journal.pntd.0004445. eCollection 2016 Feb.

18.

CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of Hypercholesterolemia.

Foster GA, Xu L, Chidambaram AA, Soderberg SR, Armstrong EJ, Wu H, Simon SI.

J Immunol. 2015 Dec 1;195(11):5380-92. doi: 10.4049/jimmunol.1501077. Epub 2015 Oct 30.

19.

Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors.

Stramer SL, Moritz ED, Foster GA, Ong E, Linnen JM, Hogema BM, Mak M, Chia CP, Dodd RY.

Transfusion. 2016 Feb;56(2):481-8. doi: 10.1111/trf.13355. Epub 2015 Oct 4.

PMID:
26434952
20.

Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012.

Dodd RY, Foster GA, Stramer SL.

Transfus Med Rev. 2015 Jul;29(3):153-61. doi: 10.1016/j.tmrv.2015.03.001. Epub 2015 Mar 22. Review.

PMID:
25841631
21.

Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States.

Moritz ED, Winton CS, Johnson ST, Krysztof DE, Townsend RL, Foster GA, Devine P, Molloy P, Brissette E, Berardi VP, Stramer SL.

Transfusion. 2014 Sep;54(9):2226-36. doi: 10.1111/trf.12693. Epub 2014 May 28.

PMID:
24865803
22.

Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007.

Grinev A, Chancey C, Añez G, Ball C, Winkelman V, Williamson P, Foster GA, Stramer SL, Rios M.

Int J Environ Res Public Health. 2013 Sep 23;10(9):4486-506. doi: 10.3390/ijerph10094486.

23.

On-chip phenotypic analysis of inflammatory monocytes in atherogenesis and myocardial infarction.

Foster GA, Gower RM, Stanhope KL, Havel PJ, Simon SI, Armstrong EJ.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13944-9. doi: 10.1073/pnas.1300651110. Epub 2013 Aug 5.

24.

IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.

Sun C, Alkhoury K, Wang YI, Foster GA, Radecke CE, Tam K, Edwards CM, Facciotti MT, Armstrong EJ, Knowlton AA, Newman JW, Passerini AG, Simon SI.

Circ Res. 2012 Sep 28;111(8):1054-64. Epub 2012 Aug 8.

25.

On-chip endothelial inflammatory phenotyping.

DeVerse JS, Bailey KA, Foster GA, Mittal V, Altman SM, Simon SI, Passerini AG.

J Vis Exp. 2012 Jul 21;(65):e4169. doi: 10.3791/4169.

26.

A Tri-service perspective on the implementation of a centering pregnancy model in the military.

Foster GA, Alviar A, Neumeier R, Wootten A.

J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):315-321. doi: 10.1111/j.1552-6909.2012.01345.x. Review.

PMID:
22834853
27.

Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico.

Stramer SL, Linnen JM, Carrick JM, Foster GA, Krysztof DE, Zou S, Dodd RY, Tirado-Marrero LM, Hunsperger E, Santiago GA, Muñoz-Jordan JL, Tomashek KM.

Transfusion. 2012 Aug;52(8):1657-66. doi: 10.1111/j.1537-2995.2012.03566.x. Epub 2012 Feb 17.

PMID:
22339201
28.

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.

Transfusion. 2012 Feb;52(2):440-6. doi: 10.1111/j.1537-2995.2011.03283.x. Epub 2011 Aug 2.

PMID:
21810101
29.

Nucleic acid testing to detect HBV infection in blood donors.

Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.

N Engl J Med. 2011 Jan 20;364(3):236-47. doi: 10.1056/NEJMoa1007644.

30.

CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1.

Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, Knowlton AA, Simon SI.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6. doi: 10.1161/ATVBAHA.110.215434. Epub 2010 Oct 28.

31.

West Nile fever characteristics among viremic persons identified through blood donor screening.

Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL.

J Infect Dis. 2010 Nov 1;202(9):1354-61. doi: 10.1086/656602.

PMID:
20874087
32.

Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007.

Brennan CA, Yamaguchi J, Devare SG, Foster GA, Stramer SL.

Transfusion. 2010 Dec;50(12):2707-12. doi: 10.1111/j.1537-2995.2010.02767.x.

PMID:
20576010
33.

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.

Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL.

Transfusion. 2010 Jul;50(7):1495-504. doi: 10.1111/j.1537-2995.2010.02622.x. Epub 2010 Mar 12.

PMID:
20345570
34.

CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.

Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, Stramer SL, Murphy PM.

J Infect Dis. 2010 Jan 15;201(2):178-85. doi: 10.1086/649426.

35.

Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.

Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM.

PLoS Pathog. 2009 Feb;5(2):e1000321. doi: 10.1371/journal.ppat.1000321. Epub 2009 Feb 27.

36.

Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.

Brennan CA, Stramer SL, Holzmayer V, Yamaguchi J, Foster GA, Notari Iv EP, Schochetman G, Devare SG.

Transfusion. 2009 Jan;49(1):125-33. doi: 10.1111/j.1537-2995.2008.01935.x. Epub 2008 Oct 2.

PMID:
18954404
38.
39.

Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Prince HE, Lapé-Nixon M, Busch MP, Tobler LH, Foster GA, Stramer SL.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1123-6.

40.

Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP.

J Clin Microbiol. 2005 Sep;43(9):4316-20.

41.

Molecular adhesion development in a neural cell monolayer forming in an ultrasound trap.

Bazou D, Foster GA, Ralphs JR, Coakley WT.

Mol Membr Biol. 2005 May-Jun;22(3):229-40. Erratum in: Mol Membr Biol. 2005 Jul-Aug;22(4):373.

PMID:
16096265
42.

West Nile virus among blood donors in the United States, 2003 and 2004.

Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY.

N Engl J Med. 2005 Aug 4;353(5):451-9.

43.

Cell-cell contact and membrane spreading in an ultrasound trap.

Coakley WT, Bazou D, Morgan J, Foster GA, Archer CW, Powell K, Borthwick KA, Twomey C, Bishop J.

Colloids Surf B Biointerfaces. 2004 Apr 15;34(4):221-30.

PMID:
15261061
44.
45.

Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?

Douketis JD, Crowther MA, Foster GA, Ginsberg JS.

Am J Med. 2001 May;110(7):515-9.

PMID:
11343664
46.

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS.

Arch Intern Med. 2000 Dec 11-25;160(22):3431-6.

PMID:
11112236
47.

Prelabor rupture of the membranes at term: expectant management at home or in hospital? The TermPROM Study Group.

Hannah ME, Hodnett ED, Willan A, Foster GA, Di Cecco R, Helewa M.

Obstet Gynecol. 2000 Oct;96(4):533-8.

PMID:
11004354
48.

Genetic regulatory elements introduced into neural stem and progenitor cell populations.

Foster GA, Stringer BM.

Brain Pathol. 1999 Jul;9(3):547-67. Review.

PMID:
10416993
49.

Predictors of cesarean delivery after prelabor rupture of membranes at term.

Peleg D, Hannah ME, Hodnett ED, Foster GA, Willan AR, Farine D.

Obstet Gynecol. 1999 Jun;93(6):1031-5.

PMID:
10362176
50.

Ionic mechanisms underlying excitatory effects of serotonin on embryonic rat motoneurons in long-term culture.

Elliott P, Wallis DI, Foster GA, Stringer BM.

Neuroscience. 1999;90(4):1311-23.

PMID:
10338299

Supplemental Content

Loading ...
Support Center